Company intelligence / Profile preview

Tap Health

Ownership: Private
Development stage: Other

Overview

Tap Health has developed an AI-powered health assistant app aimed at simplifying access to medical advice and services. The company focuses on addressing late diagnosis of illnesses by providing instant answers to health questions and connecting users with appropriate care. Their minimum viable product was launched in 2024, achieving over 10,000 downloads in the first month. No clinical trial results are reported as this is a digital health tool.

Therapeutic areas: Infectious DiseasesOther
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Tap Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tap Health.

Explore the full profile